Search results
Author(s):
Muthiah Vaduganathan
Added:
2 years ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each…
View more
Timing of Heart Transplantation & LVADs
Video Series
Timing of Heart Transplantation & LVADs
Author(s):
Espeed Khoshbin, Owais Dar,
Start date:
Nov 05, 2024
Broadcast
Martha Gulati
Research Area(s) / Expertise:
Author
Elena Gavrila
Research Area(s) / Expertise:
Job title: Chief Resident, Internal Medicine
Author
CTI Ablation: Block Assessment Review
Author(s):
Juan Ismael Almonte
,
Jesús Rodríguez-Silva
,
Julián Rodríguez-García
,
et al
Added:
4 days ago
Review Article
Author(s):
Erwan Donal
Added:
2 months ago
ACC 2026 - Two randomised trials position TriClip TEER as a transformative option in TR, delivering significant reductions in heart failure hospitalisations and supporting earlier intervention in clinical practice.Prof Erwan Donal (Hospital Pontchaillou of Rennes, Rennes, FR) joins us on-site at ACC 2026 to share the findings from two randomised trials (Tri.Fr and TRILUMINATE Pivotal)…
View more
Added:
4 months ago
Source:
Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments…
View more
Author(s):
Daniel García Iglesias
,
Fernando López Iglesias
,
Rodrigo Ariel di Massa
,
et al
Added:
2 months ago